Stock screenerAll disclosures →
EDGAR →
ELUT
Conviction 34HealthcareScan · Thu, Jun 25, 2026ELUT$0.9484-3.33%
ResistanceSupportVol 14Vol MA14 94.49K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price0.9484
Change-3.33%
Gap+0.88%
Rel volume2.09×
Avg volume104.75K
Avg $ vol106.21K
SMA 201.01
SMA 501.05
SMA 2000.9531
Price vs 50-9.98%
Price vs 200-0.50%
MA stackmixed
50/200 cross—
Supertrenddown · 1.20
RSI (14)42
MACD hist-0.00
MACD crossbear · 0d
Stoch %K / %D11 / 33
ADX (14)15
+DI / −DI17 / 16
RSI divergenceBullish
MACD divergence—
ATR %+8.23%
ADR %7.57%
52w high2.46
52w low0.5050
From 52w high-61.45%
Above 52w low+87.80%
New 52w highNo
SqueezeOn · 1d
Bollinger width21.88%
%B0.21
Donchian pos7.36%
Donchian high1.18
Donchian low0.9300
AVWAP (52w high)0.9416
vs AVWAP high+0.72%
AVWAP (52w low)0.8829
vs AVWAP low+7.41%
OBV trendDown
Chaikin MF (20)-0.25
Today vs 20d2.09×
Avg vol (14d)94.49K
Avg vol (20d)104.75K
Avg $ vol (20d)106.21K
Market cap615.21K
RS 3m (vs SPY)-19.70%
RS 6m (vs SPY)+59.60%
RS line new highNo
Trend template1/8
Technical rank46.6
1 week-4.34%
1 month-16.81%
3 months-15.32%
6 months+72.94%
1 year-45.18%
YTD+47.45%
P/E0.01
P/B0.03
P/S0.05
P/FCF-0.01
EPS0.8700
Div yield—
ROE236.96%
ROA96.69%
Debt/Eq1.16
Current2.05
EV/EBITDA0.07
Gross margin53.66%
Net margin434.23%
Rev growth-15.03%
EPS growth198.95%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value-1.77M
Revenue3.11M
Net income-7.47M
Gross profit1.8M
Free cash flow-46.69M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out44.21M
Employees26
ListedThu, Oct 8, 2020
Free float32.15M
Float %72.7%
Short interest42.63K
Days to cover0.4d
Short volume17.2%
Squeeze score17 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction34 / 100
Pattern quality—
Tech rank46.6 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.23
Support0.9400
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ELUT
No recent disclosed trades by Congress in ELUT. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ELUT · 1 buy · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Mills C Randal PRESIDENT AND CEO · Class A Common Stock · 2026-06-21 | Exercise | 22.47K | — | 2026-06-21 | 2026-06-22 |
Mills C Randal PRESIDENT AND CEO · Class A Common Stock · 2026-06-21 | Tax | 8.06K | $9K | 2026-06-21 | 2026-06-22 |
Mills C Randal PRESIDENT AND CEO · Restricted Stock Units · 2026-06-21 | Exercise | 22.47K | — | 2026-06-21 | 2026-06-22 |
SEC filings
EDGAR filings in ELUT · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.